{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:29:08Z","timestamp":1792153748208,"version":"4.4.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:00:00Z","timestamp":1626307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p><jats:italic>Mycoplasma pneumoniae<\/jats:italic> pneumonia (MPP) is an important disease in children. Studies have demonstrated that the levels of D-dimer are elevated in some children with MPP, especially those with thrombotic complications. However, the potential association between MPP and D-dimer remains unclear. In our study, we sought to explore the relationship between the levels of plasma D-dimer and clinical characteristics of MPP patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Retrospective analysis was conducted on 356 patients who were hospitalized in our hospital for MPP between January 1, 2017, and December 31, 2019. According to the peak value of D-dimer, patients were divided into three groups: the normal group (D-dimer&amp;lt;0.55 mg\/L), the mild-moderately elevated group (D-dimer 0.55\u20135.5 mg\/L) and the severely elevated group (D-dimer &amp;gt;5.5 mg\/L). The demographic and clinical information, radiological findings, laboratory data, and treatments of patients were compared among different groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>106 patients were in the normal group, 204 patients were in the mild-moderately elevated group, and 46 patients were in the severely elevated group. More severe clinical and radiographic manifestations, longer length of fever, hospital stay and antibiotic therapy duration, higher incidences of extra-pulmonary complications, refractory MPP (RMPP), severe MPP (SMPP) were found in the elevated group, when compared with the normal group (<jats:italic>P<\/jats:italic>&amp;lt;0.01). Meanwhile, we found that the percentage of neutrophil (N%) and CD<jats:sub>8<\/jats:sub><jats:sup>+<\/jats:sup> lymphocyte (CD<jats:sub>8<\/jats:sub><jats:sup>+<\/jats:sup>%), C-reactive protein (CRP), lactate dehydrogenase (LDH), interleukin (IL)-6, IL-10, and interferon-gamma (IFN-\u03b3) trended higher with increasing D-dimer, whereas the percentage of lymphocyte (L%) and prealbumin (PAB) trended lower (<jats:italic>P<\/jats:italic>&amp;lt;0.01). In addition, the proportions of patients requiring oxygen therapy, glucocorticoid, bronchoscopy, immunoglobulin use, thoracentesis, or ICU admission were significantly higher in the severely elevated group than those in the other two groups (<jats:italic>P<\/jats:italic>&amp;lt;0.01). Correlation analysis showed that N%, L%, CRP, LDH, IL-10, length of fever, length of stay, and length of antibiotic therapy had strong correlations with the level of D-dimer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>MPP patients with higher levels of D-dimer had more severe clinical manifestations and needed longer duration of treatment, which might be closely related to the severity of lung inflammation after MP infection.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2021.687391","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T11:25:04Z","timestamp":1626348304000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":66,"title":["The Level of D-Dimer Is Positively Correlated With the Severity of Mycoplasma pneumoniae Pneumonia in Children"],"prefix":"10.3389","volume":"11","author":[{"given":"Yan","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiannan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meixia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingshuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1182\/blood-2008-06-165845","article-title":"D-dimer antigen: current concepts and future prospects","volume":"113","author":"Adam","year":"2009","journal-title":"Blood"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/S1473-3099(20)30253-X","article-title":"Pulmonary Embolism Associated With Mycoplasma in a Child","volume":"20","author":"Chen","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12931-019-1152-5","article-title":"Critical Combination of Initial Markers for Predicting Refractory Mycoplasma Pneumoniae Pneumonia in Children: A Case Control Study","volume":"20","author":"Choi","year":"2019","journal-title":"Respir. Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1056\/NEJMoa040161","article-title":"Mountain States Regional Thrombophilia Group. Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children","volume":"351","author":"Goldenberg","year":"2004","journal-title":"N Engl. J. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12879-020-05700-5","article-title":"Clinical Significance of D-Dimer Levels in Refractory Mycoplasma Pneumoniae Pneumonia","volume":"21","author":"Huang","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1113\/expphysiol.2014.079525","article-title":"Inflammation and Oxidative Stress During Intermittent Hypoxia: The Impact on Chemoreception","volume":"100","author":"Iturriaga","year":"2015","journal-title":"Exp. Physiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1056\/NEJMoa1405870","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. children","volume":"372","author":"Jain","year":"2015","journal-title":"N Engl. J. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"5025","DOI":"10.3892\/etm.2018.6873","article-title":"Assessment of Levels of D-Dimer and Interferon-\u03b3 in Pediatric Patients With Mycoplasma Pneumoniae Pneumonia and its Clinical Implication","volume":"16","author":"Jin","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3345\/kjp.2016.59.3.149","article-title":"Complete Occlusion of the Right Middle Cerebral Artery Associated With Mycoplasma Pneumoniae Pneumonia","volume":"59","author":"Kang","year":"2016","journal-title":"Korean J. Pediatr."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e0177842","DOI":"10.1371\/journal.pone.0177842","article-title":"Evaluation of a Real-Time Method of Simultaneous Amplification and Testing in Diagnosis of Mycoplasma Pneumoniae Infection in Children With Pneumonia","volume":"12","author":"Li","year":"2017","journal-title":"PloS One"},{"key":"B11","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1186\/s12879-020-05270-6","article-title":"Identify Clinical Factors Related to Mycoplasma Pneumoniae Pneumonia With Hypoxia in Children","volume":"20","author":"Ling","year":"2020","journal-title":"BMC Infect. Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12879-020-4774-9","article-title":"Mycoplasma Pneumoniae Pneumonia Associated Thrombosis at Beijing Children\u2019s Hospital","volume":"20","author":"Liu","year":"2020","journal-title":"BMC Infect. Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1177\/0300060517709613","article-title":"Evaluation of Variation in Coagulation Among Children With Mycoplasma Pneumoniae Pneumonia: A Case-Control Study","volume":"45","author":"Li","year":"2017","journal-title":"J. Int. Med. Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.4187\/respcare.03920","article-title":"Lactate Dehydrogenase as a Biomarker for Prediction of Refractory Mycoplasma Pneumoniae Pneumonia in Children","volume":"60","author":"Lu","year":"2015","journal-title":"Respir. Care"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.01109","article-title":"Stroke Associated With Recent Mycoplasma Pneumoniae Infection: A Systematic Review of Clinical Features and Presumed Pathophysiological Mechanisms","volume":"9","author":"M\u00e9l\u00e9","year":"2018","journal-title":"Front. Neurol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1001\/jamadermatol.2019.3602","article-title":"Frequency and Clinical Presentation of Mucocutaneous Disease Due to Mycoplasma Pneumoniae Infection in Children With Community-Acquired Pneumonia","volume":"156","author":"Meyer Sauteur","year":"2020","journal-title":"JAMA Dermatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"10061","DOI":"10.26355\/eurrev_202010_23223","article-title":"Venous Thromboembolism During Mycoplasma Pneumoniae Infection: Case Report and Review of the Literature","volume":"24","author":"Mirijello","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.intimp.2015.07.008","article-title":"Hypoxia Modulates Innate Immune Factors: A Review","volume":"28","author":"Mishra","year":"2015","journal-title":"Int. Immunopharmacol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.pediatrneurol.2009.04.012","article-title":"Pathogenesis of Neurologic Manifestations of Mycoplasma Pneumoniae Infection","volume":"41","author":"Narita","year":"2009","journal-title":"Pediatr. Neurol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/ppul.20445","article-title":"Cytokines Involved in the Severe Manifestations of Pulmonary Diseases Caused by Mycoplasma Pneumoniae","volume":"42","author":"Narita","year":"2007","journal-title":"Pediatr. Pulmonol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1056\/NEJMp048150","article-title":"D-Dimer, and Thromboembolism in Children","volume":"351","author":"Nowak-G\u00f6ttl","year":"2004","journal-title":"N Engl. J. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s10156-012-0390-y","article-title":"A case of splenic infarction possibly attributable to Mycoplasma pneumoniae infection without accompanying pneumonia","volume":"18","author":"Park","year":"2012","journal-title":"J. Infect. Chemother."},{"key":"B23","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/BOR.0000000000000494","article-title":"Extra-Pulmonary Diseases Related to Mycoplasma Pneumoniae in Children: Recent Insights Into the Pathogenesis","volume":"30","author":"Poddighe","year":"2018","journal-title":"Curr. Opin. Rheumatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jdmv.2020.05.003","article-title":"Association Between D-Dimer Levels and Mortality in Patients With Coronavirus Disease 2019 (COVID-19): A Systematic Review and Pooled Analysis","volume":"45","author":"Sakka","year":"2020","journal-title":"J. Med. Vasc."},{"key":"B25","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.ejim.2011.10.019","article-title":"D-dimer levels in assessing severity and clinical outcome in patients with community-acquired pneumonia. A secondary analysis of a randomised clinical trial","volume":"23","author":"Snijders","year":"2012","journal-title":"Eur. J. Intern. Med."},{"key":"B26","first-page":"745","article-title":"The Society of Pediatrics, Chinese Medical Association; Editorial Board, Chinese Journal of Pediatrics. [Guidelines for Management of Community Acquired Pneumonia in Children (the Revised Edition of 2013) (I)]","volume":"51","year":"2013","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"B27","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jinf.2008.06.012","article-title":"Methylprednisolone Pulse Therapy for Refractory Mycoplasma Pneumoniae Pneumonia in Children","volume":"57","author":"Tamura","year":"2008","journal-title":"J. Infect."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1378\/chest.121.5.1493","article-title":"Role of Interleukin-18 and T-Helper Type 1 Cytokines in the Development of Mycoplasma Pneumoniae Pneumonia in Adults","volume":"121","author":"Tanaka","year":"2002","journal-title":"Chest"},{"key":"B29","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/j.1442-200X.2010.03316.x","article-title":"Japanese Guidelines for the Management of Respiratory Infectious Diseases in Children 2007 With Focus on Pneumonia","volume":"53","author":"Uehara","year":"2011","journal-title":"Pediatr. Int."},{"key":"B30","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1128\/CMR.17.4.697-728.2004","article-title":"Mycoplasma Pneumoniae and its Role as a Human Pathogen","volume":"17","author":"Waites","year":"2004","journal-title":"Clin. Microbiol. Rev."},{"key":"B31","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1128\/CMR.00114-16","article-title":"Mycoplasma Pneumoniae From the Respiratory Tract and Beyond","volume":"30","author":"Waites","year":"2017","journal-title":"Clin. Microbiol. Rev."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e22887","DOI":"10.1002\/jcla.22887","article-title":"Impact of Atopy on the Severity and Extrapulmonary Manifestations of Childhood Mycoplasma Pneumoniae Pneumonia","volume":"33","author":"Wang","year":"2019","journal-title":"J. Clin. Lab. Anal."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1016\/j.jacc.2017.09.024","article-title":"A Test in Context: D-Dimer","volume":"70","author":"Weitz","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e292","DOI":"10.1542\/peds.2006-1340","article-title":"Mycoplasma Pneumoniae, Splenic Infarct, and Transient Antiphospholipid Antibodies: A New Association","volume":"119","author":"Witmer","year":"2007","journal-title":"Pediatrics"},{"key":"B35","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1007\/s11239-020-02171-y","article-title":"Evaluation of Variation in D-Dimer Levels Among COVID-19 and Bacterial Pneumonia: A Retrospective Analysis","volume":"50","author":"Yu","year":"2020","journal-title":"J. Thromb. Thrombolysis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.4187\/respcare.03032","article-title":"Effects of Bronchoalveolar Lavage on Refractory Mycoplasma Pneumoniae Pneumonia","volume":"59","author":"Zhang","year":"2014","journal-title":"Respir. Care"},{"key":"B37","doi-asserted-by":"publisher","first-page":"37037","DOI":"10.1038\/srep37037","article-title":"Cytokines as the Good Predictors of Refractory Mycoplasma Pneumoniae Pneumonia in School-Aged Children","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1111\/jth.14859","article-title":"D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19","volume":"18","author":"Zhang","year":"2020","journal-title":"J.\u00a0Thromb. Haemost."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1128\/AAC.01806-13","article-title":"More Complications Occur in Macrolide-Resistant Than in Macrolide-Sensitive Mycoplasma Pneumoniae Pneumonia","volume":"58","author":"Zhou","year":"2014","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2021.687391\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T11:25:07Z","timestamp":1626348307000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2021.687391\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,15]]},"references-count":39,"alternative-id":["10.3389\/fcimb.2021.687391"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2021.687391","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,15]]},"article-number":"687391"}}